Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.40 |
| ▸ | NT5E | P21589 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7959759 | 0.93 | LGALS8 (0.44) | ALDH1A1MAPK1L3MBTL1RAB9ALGALS8 | |
| SCHEMBL7957798 | 0.93 | ALDH1A1 (0.43) | ALDH1A1MAPK1L3MBTL1RAB9ALGALS8 | |
| SCHEMBL7955544 | 0.80 | NT5E (0.47) | ALDH1A1RAB9ANT5ENPC1HTR2A | |
| SCHEMBL7957304 | 0.73 | NT5E (0.49) | ALDH1A1RAB9ANT5ENPC1 | |
| SCHEMBL7955492 | 0.73 | NT5E (0.49) | ALDH1A1RAB9ANT5ENPC1 | |
| SCHEMBL15782553 | 0.73 | CA12 (0.48) | ALDH1A1GAA | |
| SCHEMBL7596584 | 0.73 | CA12 (0.48) | ALDH1A1GAA | |
| SCHEMBL4609138 | 0.73 | CA12 (0.48) | ALDH1A1GAA | |
| SCHEMBL2296345 | 0.73 | CA12 (0.48) | ALDH1A1GAA | |
| SCHEMBL2943984 | 0.73 | CA12 (0.48) | ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6271342-B1 | SERUM STABILITY; FOR TUMOR THERAPY | BAYER AKTIENGESELLSCHAFT (DE) | 2001-08-07 | — | — | US | disclosed |
| EP-0819135-B1 | SUGAR-MODIFIED CYTOSTATICS | BAYER AG (DE) | 1999-11-17 | — | — | EP | disclosed |